StockData
First Tracks Biotherapeutics, Inc. logo

First Tracks Biotherapeutics, Inc. (TRAX) income statement

TRAXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 3, 2026
$44.46−0.04 (-0.09%)

Close on Nov 19, 2026Market cap $1.59BP/E –Yield –

First Tracks Biotherapeutics, Inc. financial ratios

See a number that looks wrong?